Advanced Ovarian Cancer and Peripheral Blood Stem Cell Transplantation
Links shared publicly online about this topic
SCCA Clinical Trials | Multiple Myeloma | NCT01208662
seattlecca.org — “A Randomized Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age (IFM/DFCI 2009) Seattle Cancer Care Alliance is a nationally recognized treatment center that provides advanced therapies and clinical trials for cancers and other blood disorders. SCCA unites the doctors and technology from Fred ” View full resource at seattlecca.org
Most Recently Shared on August 25, 2011 at 7:27 pm By:
ReedMedicalEducation Medical Education
RT @seattlecca: New! Multiple myeloma trial compares combo of lenalidomide, bortezomib and dexamethasone (RVD) to BMT. http://ow.ly/69xMR
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
ReedMedicalEducation
Impactful live and online education for oncology clinicians, including Oncology Congress, Chemotherapy Foundation Symposium, and more.
Advertisement
